findmyKOL

Ashish Kumar, MBBS

Basic profile

Mayo Clinic

ORCIDNone on fileNPI
RegionRochester, MN · MidwestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH funding2007–2008Why? →

Ashish Kumar is a Cardiology physician affiliated with Mayo Clinic. OpenAlex indexes 23 publications with 346 citations (h-index 11); ClinicalTrials.gov lists 5 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
23publications

Distinct works indexed by OpenAlex.

346citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials
1NIH grants · 2007–2008

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

200 1st St SW
Rochester, MN 559050001

Telephone

507-284-2511

Provider last certified this registry record 7 Oct 2024.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    51.8%
    Statin17.9%
    Atorvastatin Calcium100%
    Part D23 patients
    Calcium channel blocker11.1%
    Amlodipine Besylate100%
    Part D<11 patients

    + 4 more classes in this area

  • Metabolism & gastrointestinal

    14.5%
    Biguanide (metformin)10%
    Metformin Hcl Er66%Metformin Hcl34%
    Part D<11 patients
    Proton pump inhibitor4.5%
    Pantoprazole Sodium100%
    Part D<11 patients
  • Blood & clotting

    11.6%
    P2Y12 inhibitor5%
    Brilinta100%
    Part D<11 patients
    Low Molecular Weight Heparin3.4%
    Enoxaparin Sodium100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20072008 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”